Abstract
Purpose
To determine the incidence and determinants of developing abnormalities on the 12-lead electrocardiogram (ECG) in persons with type 1 diabetes.
Methods
We evaluated the distribution of ECG abnormalities and risk factors for developing new abnormalities in 266 (mean age = 44 years ± 9.0; 50 % female) people with type 1 diabetes from the Wisconsin Epidemiologic Study of Diabetic Retinopathy. This analysis included participants with complete ECG data from study visit 5 (2000–2001) and follow-up ECGs from study visit 7 (2012–2014). ECG abnormalities were classified as major and minor according to Minnesota Code Classification.
Results
At baseline, 94 (35 %) participants had at least one ECG abnormality, including 13 major ECG abnormalities. At follow-up, 117 (44 %) participants developed at least one new ECG abnormality, including 35 new major ECG abnormalities. In a multivariable logistic regression model, older age (per 5-year increase: OR = 1.31, 95 % CI = 1.08, 1.60) was associated with the development of at least one new ECG abnormality, while serum HDL cholesterol (per 10-unit increase: OR = 0.98, 95 % CI = 0.96, 1.00) was protective against developing new ECG abnormalities.
Conclusions
The development of new ECG abnormalities is common in type 1 diabetes. Older age and HDL cholesterol are independent risk factors for developing new ECG abnormalities. Further research is needed to determine whether routine ECG screening is indicated in people with type 1 diabetes to identify those with underlying subclinical coronary heart disease.
Similar content being viewed by others
References
Laing SP, Swerdlow AJ, Slater SD, Burden AC, Morris A, Waugh NR, Gatling W, Bingley PJ, Patterson CC (2003) Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes. Diabetologia 46:760–765
Klein BE, Klein R, McBride PE, Cruickshanks KJ, Palta M, Knudtson MD, Moss SE, Reinke JO (2004) Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin epidemiologic study of diabetic retinopathy. Arch Intern Med 164:1917–1924
Dawson SI, Willis J, Florkowski CM, Scott RS (2008) Cause-specific mortality in insulin-treated diabetic patients: a 20-year follow-up. Diabetes Res Clin Pract 80:16–23
MacDonald MR, Petrie MC, Home PD, Komajda M, Jones NP, Beck-Nielsen H, Gomis R, Hanefeld M, Pocock SJ, Curtis PS, McMurray JJ (2011) Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) study. Diabetes Care 34:1394–1396
Davis TM, Coleman RL, Holman RR, Group U (2013) Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79. Circulation 127:980–987
Rutter MK, Wahid ST, McComb JM, Marshall SM (2002) Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes. J Am Coll Cardiol 40:56–61
Klein BE, Klein R, McBride PE, Moss SE, Prineas RJ, Reinke JO (2005) Electrocardiographic abnormalities in individuals with long-duration type 1 diabetes. Diabetes Care 28:145–147
Klein BE, Myers CE, Howard KP, Klein R (2015) Serum lipids and proliferative diabetic retinopathy and macular edema in persons with long-term type 1 diabetes mellitus: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. JAMA Ophthalmol 133:503–510
Prineas RJ, Crow RS, Zhang ZM (2010) The Minnesota code manual of electrocardiographic findings: standards and procedures for measurement and classification, 2nd edn. Springer, London
Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, Hogg RJ, Perrone RD, Lau J, Eknoyan G, National Kidney F (2003) National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139:137–147
O’Sullivan JJ, Conroy RM, MacDonald K, McKenna TJ, Maurer BJ (1991) Silent ischaemia in diabetic men with autonomic neuropathy. Br Heart J 66:313–315
Marchant B, Umachandran V, Stevenson R, Kopelman PG, Timmis AD (1993) Silent myocardial ischemia: role of subclinical neuropathy in patients with and without diabetes. J Am Coll Cardiol 22:1433–1437
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, Lloyd-Jones DM, McBride P, Schwartz JS, Shero ST, Smith SC Jr, Watson K, Wilson PW, American College of Cardiology, American Heart Association Task Force on Practice G (2014) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63:2889–2934
Mosca L, Manson JE, Sutherland SE, Langer RD, Manolio T, Barrett-Connor E, Writing Group (1997) Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Circulation 96:2468–2482
Denes P, Larson JC, Lloyd-Jones DM, Prineas RJ, Greenland P (2007) Major and minor ECG abnormalities in asymptomatic women and risk of cardiovascular events and mortality. JAMA 297:978–985
Auer R, Bauer DC, Marques-Vidal P, Butler J, Min LJ, Cornuz J, Satterfield S, Newman AB, Vittinghoff E, Rodondi N, Health ABCS (2012) Association of major and minor ECG abnormalities with coronary heart disease events. JAMA 307:1497–1505
Acknowledgments
The authors would like to thank Jennifer Dreyer and Lorraine Danforth for their assistance with the collection and management of electrocardiogram data in the Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Funding
Drs. R. Klein and B. E. K. Klein were supported by grant HL59259 from the National Heart, Lung, and Blood Institute, grant EY016379 from the National Eye Institute, and an unrestricted grant from Research to Prevent Blindness, New York, New York. Dr. W. T. O’Neal is supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number F32HL134290. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicts of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed Consent
Informed consent was obtained from all individual participants included in the study.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
O’Neal, W.T., Lee, K.E., Soliman, E.Z. et al. Predictors of electrocardiographic abnormalities in type 1 Diabetes: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. J Endocrinol Invest 40, 313–318 (2017). https://doi.org/10.1007/s40618-016-0564-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40618-016-0564-z